LPV/r 100+25mg Heat-Stable Tablets are powered with potent antiretroviral agents, Lopinavir (100mg) and Ritonavir (25mg). Preferred choice for combatting HIV-1 in adults and children over the age of 2. Specially designed for effective infection management and prolonged stability in varying heat conditions. Stored under 30u00b0, these tablets stay effective for 24 months in their original packaging. Important: Tablets should be swallowed whole and not crushed before administration.
Our LPV/r 100+25mg tablets mark an innovative step forward in the fight against HIV-1. Embedded in each tablet are the potent protease inhibitors Lopinavir (100mg) and Ritonavir (25mg), which work synergistically to contain viral spread. Optimized for use on a global scale, they're designed to be heat-stable, a feature crucial in ensuring their efficacy across diverse environmental conditions.
LPV/r tablets stand out due to their unique focus on containing HIV replication within the body. Utilizing Lopinavir and Ritonavir, these tablets decrease the viral load, aiding in the successful management of HIV-1 in combination with at least two other antiretroviral drugs, thus part of an effective HIV treatment protocol.
Suitable for both children (over 2 years of age) and adults, the LPV/r tablets bring a versatile treatment approach to fit different demographic needs. Determined by body weight and health condition, dosage varies and should be under the strict guidance of a healthcare professional.
One of the key features of our LPV/r tablets is the unique heat-stable formula. This ensures that the tablets maintain their potency and effectiveness, even under varying environmental conditions, making them suitable for use across the world.
Designed in accordance with WHO or regional national treatment guidelines, LPV/r 100+25mg is a comprehensive solution in the global fight against HIV-1.